Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Topiramate Glauser TAEpilepsia 1999[]; 40 Suppl 5 (ä): S71-80Six studies are cited to demonstrate that topiramate is effective as adjunctive therapy for refractory partial-onset seizures in adults. Subsequent studies indicate that topiramate is also effective as monotherapy in adults and as adjunctive therapy for partial-onset seizures in children, tonic-clonic seizures of nonfocal origin in children and adults, and drop attacks in Lennox-Gastaut syndrome. Adverse effects for adults and children included dizziness, fatigue, ataxia, confusion, somnolence, nephrolithiasis, paresthesia, and weight loss. More adverse effects were observed at higher doses. Topiramate exhibits rapid absorption, long duration of action, and minimal interaction with other antiepileptic drugs.|Adult[MESH]|Anticonvulsants/adverse effects/*therapeutic use[MESH]|Ataxia/chemically induced[MESH]|Child[MESH]|Clinical Trials as Topic[MESH]|Dizziness/chemically induced[MESH]|Dose-Response Relationship, Drug[MESH]|Drug Therapy, Combination[MESH]|Epilepsies, Partial/drug therapy[MESH]|Epilepsy/*drug therapy[MESH]|Fatigue/chemically induced[MESH]|Fructose/adverse effects/*analogs & derivatives/therapeutic use[MESH]|Humans[MESH]|Topiramate[MESH]|Treatment Outcome[MESH] |
